Detailed Notes on Retene
Contraindicated (1)bortezomib will increase the level or impact of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Contraindicated. Strong or average CYP2C19 inhibitors may improve mavacamten systemic publicity, leading to heart failure because of systolic dysfunction.Unlock 38% much more drug discovery time and remove choice-earning dou